23.37
+0.75
+(3.29%)
At close: January 17 at 8:35:39 PM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 15 | 15 | 18 | 18 |
Avg. Estimate | 1.26B | 1.12B | 4.53B | 4.54B |
Low Estimate | 1.23B | 1.08B | 4.38B | 4.18B |
High Estimate | 1.29B | 1.18B | 4.63B | 4.72B |
Year Ago Sales | 1.43B | 1.22B | 5.17B | 4.53B |
Sales Growth (year/est) | -11.57% | -8.77% | -12.47% | 0.44% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
MKO.F | -- | -- | -- | -- |
S&P 500 | 9.26% | 11.36% | 13.91% | 13.52% |
Upgrades & Downgrades
Upgrade | Wells Fargo: Equal-Weight to Overweight | 1/10/2025 |
Upgrade | Citigroup: Neutral to Buy | 1/10/2025 |
Upgrade | BMO Capital: Market Perform to Outperform | 1/6/2025 |
Maintains | JP Morgan: Neutral to Neutral | 12/16/2024 |
Upgrade | Guggenheim: Neutral to Buy | 11/26/2024 |
Maintains | Telsey Advisory Group: Market Perform to Market Perform | 11/15/2024 |